Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Ipca Laboratories Limited
Ipca Laboratories Limited
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
Several large Indian pharma companies under US FDA scrutiny
Recent regulatory action by the FDA on leading Indian firms has affected the country's exports, according to Chairman of Dr. Reddy's Laboratories
You need to be a subscriber to read this article.
Click here
to find out more.
Research & Development
Syntheses that cut costs and boost yields
Reworking drug syntheses using cheaper or more environmentally friendly ingredients and catalysts can increase margins dramatically. Dr Sarah Houlton reports on recent successes
Regulatory
Indian manufacturers challenge Drug Price Control Order
Move could delay the introduction of low priced medicines in the market
Ingredients
Indian API market on the up as domestic drug prices fall
Indian API manufacturers are branching out into new markets, while international suppliers could be hit by lower prices in the domestic market, writes Asia correspondent A Nair
Ingredients
Indian pharma exports to be hit by Falsified Medicines Directive
API exporters say latest EU move is a non-issue
Manufacturing
Ipca acquires Onyx Scientific
Broadens contract manufacturing capabilities
Subscribe now